These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 27021209)

  • 1. Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator.
    Hui WQ; Cheng Q; Liu TY; Ouyang Q
    J Mol Model; 2016 Apr; 22(4):90. PubMed ID: 27021209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
    Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
    Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.
    Borroto-Escuela DO; Narvaez M; Di Palma M; Calvo F; Rodriguez D; Millon C; Carlsson J; Agnati LF; Garriga P; Díaz-Cabiale Z; Fuxe K
    Biochem Biophys Res Commun; 2014 Sep; 452(3):347-53. PubMed ID: 25152404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the molecular structures that confer ligand selectivity for galanin type II and III receptors.
    Lee YN; Reyes-Alcaraz A; Yun S; Lee CS; Hwang JI; Seong JY
    PLoS One; 2020; 15(3):e0230872. PubMed ID: 32231393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical investigation of selective ligand binding mode of galanin receptors.
    Khan SA; Zia K; Ashraf S; Khan A; Ul-Haq Z
    J Biomol Struct Dyn; 2022; 40(23):12964-12974. PubMed ID: 34632940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.
    Lu X; Roberts E; Xia F; Sanchez-Alavez M; Liu T; Baldwin R; Wu S; Chang J; Wasterlain CG; Bartfai T
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15229-34. PubMed ID: 20660766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
    Feng Z; Ma S; Hu G; Xie XQ
    AAPS J; 2015 May; 17(3):737-53. PubMed ID: 25762450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward understanding the molecular basis for chemical allosteric modulator design.
    Wang Q; Zheng M; Huang Z; Liu X; Zhou H; Chen Y; Shi T; Zhang J
    J Mol Graph Model; 2012 Sep; 38():324-33. PubMed ID: 23085171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important pharmacophores for binding to galanin receptor 2.
    Lundström L; Lu X; Langel U; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):169-71. PubMed ID: 15944008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coevolution of the spexin/galanin/kisspeptin family: Spexin activates galanin receptor type II and III.
    Kim DK; Yun S; Son GH; Hwang JI; Park CR; Kim JI; Kim K; Vaudry H; Seong JY
    Endocrinology; 2014 May; 155(5):1864-73. PubMed ID: 24517231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Screening of Novel α1-GABA
    Zheng X; Wang C; Zhai N; Luo X; Liu G; Ju X
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice.
    Badie-Mahdavi H; Lu X; Behrens MM; Bartfai T
    Neuroscience; 2005; 133(2):591-604. PubMed ID: 15885916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Modeling Study of a Receptor-Orthosteric Ligand-Allosteric Modulator Signaling Complex.
    Jiang C; He X; Wang Y; Chen CJ; Othman Y; Hao Y; Yuan J; Xie XQ; Feng Z
    ACS Chem Neurosci; 2023 Feb; 14(3):418-434. PubMed ID: 36692197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach.
    Gadhe CG; Kothandan G; Cho SJ
    J Biomol Struct Dyn; 2013; 31(11):1251-76. PubMed ID: 23153179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico characterization of binding mode of CCR8 inhibitor: homology modeling, docking and membrane based MD simulation study.
    Gadhe CG; Balupuri A; Cho SJ
    J Biomol Struct Dyn; 2015; 33(11):2491-510. PubMed ID: 25617117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.
    Robertson CR; Scholl EA; Pruess TH; Green BR; White HS; Bulaj G
    J Med Chem; 2010 Feb; 53(4):1871-5. PubMed ID: 20121116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studying the binding interactions of allosteric agonists and antagonists of the CXCR4 receptor.
    Planesas JM; Pérez-Nueno VI; Borrell JI; Teixidó J
    J Mol Graph Model; 2015 Jul; 60():1-14. PubMed ID: 26080355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.